胰腺神经内分泌肿瘤术后并发症的危险因素
该队列研究在2个卓越中心纳入123例接受胰腺神经内分泌肿瘤切除的患者,按Clavien-Dindo分级和综合并发症指数评估并发症。术后死亡率0.8%,严重并发症发生率41.5%,失败救援率2.0%;调整后胰十二指肠切除术较远端胰腺切除术增加严重并发症风险(OR 3.13,95%CI 1.32-7.41)。
要点
- 胰腺神经内分泌肿瘤术后严重并发症发生率为41.5%,死亡率0.8%,失败救援率2.0%。
- 调整后胰十二指肠切除术较远端胰腺切除术增加严重并发症风险(OR 3.13,95%CI 1.32-7.41)。
核心结论
- 胰腺神经内分泌肿瘤手术并发症发生率高,但在卓越中心失败救援率低;并发症与术式相关,MEN1/VHL患者大范围切除似乎增加并发症风险。
研究设计与样本
- 在2个卓越中心识别接受胰腺神经内分泌肿瘤切除的患者,共123例,包括12例剜除术、50例远端胰腺切除术、51例胰十二指肠切除术和10例全胰/联合胰腺切除术。
主要发现
- 死亡率0.8%,严重并发症发生率41.5%,失败救援率2.0%;综合并发症指数中位数22.6(0-100),更广泛切除后综合并发症指数升高。
- 调整后胰十二指肠切除术较远端胰腺切除术增加严重并发症风险(OR 3.13,95%CI 1.32-7.41)。
- MEN1或VHL患者中51.9%发生严重并发症,散发病例为38.5%。
临床怎么用
- 术式选择需权衡肿瘤学获益与术式特异性并发症风险,胰十二指肠切除术较远端胰腺切除术严重并发症风险更高。
- 对MEN1/VHL患者行大范围切除时,应关注其并发症风险似乎增加。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical resection is the only potentially curative treatment for pancreatic neuroendocrine tumors. The choice for the type of procedure is influenced by the expected oncological benefit and the anticipated risk of procedure-specific complications. Few studies have focused on complications in these patients. This cohort study aimed to assess complications and risk factors after resections of pancreatic neuroendocrine tumors. METHODS: Patients undergoing resection of a pancreatic neuroendocrine tumor were identified within 2 centers of excellence. Complications were assessed according to the Clavien-Dindo classification and the comprehensive complication index. Logistic regression was performed to compare surgical procedures with adjustment for potential confounders (Clavien-Dindo ≥3). RESULTS: The cohort comprised 123 patients, including 12 enucleations, 50 distal pancreatectomies, 51 pancreatoduodenectomies, and 10 total/combined pancreatectomies. Mortality was 0.8%, a severe complication occurred in 41.5%, and the failure-to-rescue rate was 2.0%. The median comprehensive complication index was 22.6 (0-100); the comprehensive complication index increased after more extensive resections. After adjustment, a pancreatoduodenectomy, as compared to a distal pancreatectomy, increased the risk for a severe complication (odds ratio 3.13 [95% confidence interval 1.32-7.41]). Of the patients with multiple endocrine neoplasia type 1 or von Hippel-Lindau, 51.9% developed a severe complication vs 38.5% with sporadic disease. After major resections, morbidity was significantly higher in patients with multiple endocrine neoplasia type 1/von Hippel-Lindau (comprehensive complication index 45.1 vs 28.9, P = .029). CONCLUSION: Surgery for pancreatic neuroendocrine tumors is associated with a high rate of complications but low failure-to-rescue in centers of excellence. Complications are procedure-specific. Major resections in patients with multiple endocrine neoplasia type 1/von Hippel-Lindau appear to increase the risk of complications.
引用
- van Beek DJ, Takkenkamp TJ, Wong-Lun-Hing EM, et al. Risk factors for complications after surgery for pancreatic neuroendocrine tumors. Surgery. 2022. PMID: 35341591. doi:10.1016/j.surg.2022.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。